Thanks for the update; very usefulI really need to try to block...

  1. 3,292 Posts.
    lightbulb Created with Sketch. 1232
    Thanks for the update; very useful

    I really need to try to block out the time to attend/dial in to these meetings given the size of my position, but good to know the operational issues are behind them.

    It does not appear that the question around contracted revenues for 1H was raised as this is a major issue IMO - 2Q is by far their most important quarter, so if they misstep in that quarter, then it basically means they are unprofitable (their cost run rate is ~18-19m per quarter, and their gross profit for 1Q was ~15m (similar to 1Q24, 3Q24 & 4Q24)......so it's really that outsized contribution from 2Q that makes/breaks the year.

    So my concern is around that contract revenue (which they should be really pushing), but this year there are external forces being the trump admin coming in....and this morning it seem that nutter JFK Jr who does not believe in vaccines & medicines was just announced as health secretary, so you have to wonder what will happen in this area (although I suspect the pharma companies are so big in the US that they will be fine, but for small companies like MDR not sure....might hurt them or perhaps the drug companies spend more on direct marketing/targeting americans?!?!?)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.3¢
Change
-0.001(1.56%)
Mkt cap ! $39.39M
Open High Low Value Volume
6.3¢ 6.3¢ 6.3¢ $1.749K 27.75K

Buyers (Bids)

No. Vol. Price($)
2 44301 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 190000 1
View Market Depth
Last trade - 14.04pm 11/08/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.